| # | Side effect | Count |
|---|---|---|
| 0 | DEATH | 406 |
| 1 | FATIGUE | 129 |
| 2 | HOT FLUSH | 127 |
| 3 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 110 |
| 4 | OFF LABEL USE | 107 |
| 5 | ASTHENIA | 89 |
| 6 | PROSTATIC SPECIFIC ANTIGEN INCREASED | 89 |
| 7 | MALIGNANT NEOPLASM PROGRESSION | 82 |
| 8 | PRODUCT DOSE OMISSION ISSUE | 82 |
| 9 | DISEASE PROGRESSION | 78 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | COVID-19 SCREENING | 1 | 0.3333 |
| 1 | CATAMENIAL PNEUMOTHORAX | 1 | 0.2500 |
| 2 | NEUROENDOCRINE BREAST TUMOUR | 4 | 0.2222 |
| 3 | DYSKALAEMIA | 1 | 0.1667 |
| 4 | BLOOD TESTOSTERONE NORMAL | 1 | 0.1111 |
| 5 | DEOXYPYRIDINOLINE URINE INCREASED | 1 | 0.1111 |
| 6 | HORMONE-DEPENDENT PROSTATE CANCER | 6 | 0.0857 |
| 7 | BONE SCAN | 1 | 0.0833 |
| 8 | BLADDER TELANGIECTASIA | 1 | 0.0769 |
| 9 | INTESTINAL TRANSIT TIME DECREASED | 3 | 0.0390 |